Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

PheCheck™ Validation Study

NCT: NCT07551921 · RECRUITING

NCT IDNCT07551921
StatusRECRUITING
Start Date2026-08-20
Completion2027-04-20
SponsorAptatek BioSciences, Inc (INDUSTRY)
First posted
Last updated

Brief Summary

The goal of this observational study is to evaluate the performance of the PheCheck™ test for the rapid detection of phenylalanine (Phe) from a fingerstick sample, in patients 1 year or older with phenylketonuria (PKU) or hyperphenylalaninemia. The main objective is comparing the concentration of phenylalanine (Phe) in capillary blood with the reference method (DBS).

Frequently Asked Questions

What is PheCheck™ Validation Study?

PheCheck™ Validation Study is a clinical trial registered under NCT07551921. Current status: RECRUITING.

What is the status of NCT07551921?

The current status of NCT07551921 (PheCheck™ Validation Study) is: RECRUITING.

When did PheCheck™ Validation Study start?

PheCheck™ Validation Study started on 2026-08-20.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑